JP6810023B2 - 構造的に多様な複合脂質を分析するための方法、組成物およびキット - Google Patents

構造的に多様な複合脂質を分析するための方法、組成物およびキット Download PDF

Info

Publication number
JP6810023B2
JP6810023B2 JP2017505546A JP2017505546A JP6810023B2 JP 6810023 B2 JP6810023 B2 JP 6810023B2 JP 2017505546 A JP2017505546 A JP 2017505546A JP 2017505546 A JP2017505546 A JP 2017505546A JP 6810023 B2 JP6810023 B2 JP 6810023B2
Authority
JP
Japan
Prior art keywords
lipid
fatty acid
internal standard
mixture
acid residues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2017505546A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017524708A5 (en,Table 1-8
JP2017524708A (ja
Inventor
ワトキンス スティーブン
ワトキンス スティーブン
Original Assignee
メタボロン，インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by メタボロン，インコーポレイテッド filed Critical メタボロン，インコーポレイテッド
Publication of JP2017524708A publication Critical patent/JP2017524708A/ja
Publication of JP2017524708A5 publication Critical patent/JP2017524708A5/ja
Application granted granted Critical
Publication of JP6810023B2 publication Critical patent/JP6810023B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/04—Preparation or injection of sample to be analysed
    • G01N2030/042—Standards
    • G01N2030/045—Standards internal
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2458/00—Labels used in chemical analysis of biological material
    • G01N2458/15—Non-radioactive isotope labels, e.g. for detection by mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00—Reference solutions for assays of biological material
    • G01N2496/80—Multi-analyte reference solutions containing cholesterol, glucose and the like
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2560/00—Chemical aspects of mass spectrometric analysis of biological material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/104165—Lipid, cholesterol, or triglyceride standard or control
JP2017505546A 2014-07-30 2015-07-30 構造的に多様な複合脂質を分析するための方法、組成物およびキット Active JP6810023B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462031099P 2014-07-30 2014-07-30
US62/031,099 2014-07-30
PCT/US2015/042904 WO2016019140A1 (en) 2014-07-30 2015-07-30 Methods, compositions, and kits for analysis of structurally diverse complex lipids

Publications (3)

Publication Number Publication Date
JP2017524708A JP2017524708A (ja) 2017-08-31
JP2017524708A5 JP2017524708A5 (en,Table 1-8) 2018-09-06
JP6810023B2 true JP6810023B2 (ja) 2021-01-06

Family

ID=55218314

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017505546A Active JP6810023B2 (ja) 2014-07-30 2015-07-30 構造的に多様な複合脂質を分析するための方法、組成物およびキット

Country Status (7)

Country Link
US (1) US11181535B2 (en,Table 1-8)
EP (1) EP3174991B1 (en,Table 1-8)
JP (1) JP6810023B2 (en,Table 1-8)
CN (1) CN107075539B (en,Table 1-8)
AU (1) AU2015296304B2 (en,Table 1-8)
CA (1) CA2955204A1 (en,Table 1-8)
WO (1) WO2016019140A1 (en,Table 1-8)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018183448A1 (en) * 2017-03-31 2018-10-04 Metabolon, Inc. Comprehensive and quatitative lipid and tocopherol analysis
JP7306676B2 (ja) * 2019-02-26 2023-07-11 国立大学法人九州大学 脂質プロファイリングシステム、脂質プロファイリング方法、及び脂質プロファイリングプログラム
AU2020287121A1 (en) * 2019-06-04 2022-01-06 Avanti Polar Lipids, Llc Universal lipid quantitative standards for use in lipidomics
CN110609097A (zh) * 2019-09-12 2019-12-24 谱尼测试集团股份有限公司 一种磷脂酰丝氨酸类化合物的筛查方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4224031A (en) * 1977-11-15 1980-09-23 Mee John M L CI Mass spectrometric analysis of physiologically active compounds
GB0128498D0 (en) * 2001-11-28 2002-01-23 Inst Of Child Health International standards for sphingolipids
WO2003078574A2 (en) 2002-03-11 2003-09-25 Lipomics Technologies, Inc. Novel metabolic targets and markers
US7306952B2 (en) * 2002-06-26 2007-12-11 Washington University In St. Louis Molecular fingerprinting of triglycerides in biological samples by electrospray ionization tandem mass spectrometry
US20070082399A1 (en) * 2003-07-11 2007-04-12 Tatiana A Egorova-Zachernyuk Compositions and method for stable isotope labelling of biological compounds
CN100567967C (zh) * 2006-08-31 2009-12-09 华南理工大学 一种定量测定纸浆树脂中甘油三酯含量的方法
US20100159540A1 (en) * 2007-03-26 2010-06-24 Ana Rodriguez Synthesis of resolvins and intermediates, compounds prepared thereby, and uses thereof
EP3059592A1 (en) * 2008-05-28 2016-08-24 Basf Se Methods for assessing liver toxicity
US8263413B1 (en) * 2008-10-17 2012-09-11 Andrew S Hansen Methods for analyzing lipids and membrane proteins in biological matter using stable isotopes and mass spectrometry
SG10201405974SA (en) * 2009-10-01 2014-10-30 Phenomenome Discoveries Inc Serum-based biomarkers of pancreatic cancer and uses thereof for diseasedetection and diagnosis
EP2345897A1 (en) * 2010-01-18 2011-07-20 Nederlandse Organisatie voor toegepast -natuurwetenschappelijk onderzoek TNO Improved method for the detection of polyunsaturated fatty acids
CN101824064A (zh) * 2010-01-29 2010-09-08 上海化工研究院 一种13c标记胆甾醇羧酸酯的合成方法
GB201213127D0 (en) * 2012-07-24 2012-09-05 Univ Dundee Novel isotopic labelling method
US10705100B1 (en) * 2013-09-11 2020-07-07 HB Biotech, LLC Methods for analyzing lipids and membrane proteins in biological matter using stable isotopes and mass spectrometry
CN103743851B (zh) * 2014-02-14 2015-06-17 中国农业科学院油料作物研究所 一种食用油中甘油三酯的单柱二维液相色谱-质谱分析方法及其应用

Also Published As

Publication number Publication date
CN107075539B (zh) 2021-11-12
US11181535B2 (en) 2021-11-23
US20170192023A1 (en) 2017-07-06
EP3174991A1 (en) 2017-06-07
EP3174991B1 (en) 2024-03-20
AU2015296304B2 (en) 2019-08-29
AU2015296304A1 (en) 2017-02-02
WO2016019140A1 (en) 2016-02-04
CA2955204A1 (en) 2016-02-04
CN107075539A (zh) 2017-08-18
JP2017524708A (ja) 2017-08-31
EP3174991A4 (en) 2018-02-14

Similar Documents

Publication Publication Date Title
Wiesner et al. Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry
US20200116743A1 (en) Method of Assessing Liver Triglyceride Levels Using a Body Fluid Sample
Özbalci et al. Quantitative analysis of cellular lipids by nano-electrospray ionization mass spectrometry
Avela et al. Advances in lipidomics
JP6810023B2 (ja) 構造的に多様な複合脂質を分析するための方法、組成物およびキット
CA2799032A1 (en) Methods to diagnose liver diseases
Scherer et al. Lipid profiling of lipoproteins by electrospray ionization tandem mass spectrometry
Holčapek et al. Lipidomic analysis of plasma, erythrocytes and lipoprotein fractions of cardiovascular disease patients using UHPLC/MS, MALDI-MS and multivariate data analysis
CA2900031A1 (en) Means and methods for assessing the quality of a biological sample
CA2724422A1 (en) Means and methods for assessing increased peroxisomal proliferation
Dyńska-Kukulska et al. Methods of extraction and thin-layer chromatography determination of phospholipids in biological samples
Zhang et al. Validation of a multiplexed and targeted lipidomics assay for accurate quantification of lipidomes
Liu et al. Lipidomics in milk: Recent advances and developments
Zhang et al. Development of a targeted hydrophilic interaction liquid chromatography-tandem mass spectrometry based lipidomics platform applied to a coronavirus disease severity study
McDonald et al. Approaches to lipid analysis
Alqarni et al. A High‐Throughput Method for the Analysis of Erythrocyte Fatty Acids and the Omega‐3 Index
Torkhovskaya et al. Human Blood Plasma Lipidome: Opportunities and Prospects of Its Analysis in Medical Chemistry
Berry et al. Analysis of polyunsaturated aminophospholipid molecular species using isotope-tagged derivatives and tandem mass spectrometry/mass spectrometry/mass spectrometry
Gao et al. Dual mass spectrometry as a tool to improve annotation and quantification in targeted plasma lipidomics
Holcapek et al. Mass spectrometry for lipidomics: methods and applications
Hewelt-Belka et al. Analytical strategies and applications in lipidomics
Li Development of metabolomics and lipidomics workflows for phosphorylated metabolites using ultra-high-performance liquid chromatography with tandem mass spectrometry
Höring et al. Direct Infusion (Shotgun) Electrospray Mass Spectrometry
Zhang et al. Development of a targeted HILIC-MS/MS based lipidomics platform applied to a coronavirus disease severity study
Lin et al. Comprehensive Mouse Skin Ceramide Analysis on a Solid-Phase and TLC Separation with High-Resolution Mass Spectrometry Platform

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180726

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180726

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190806

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20191021

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20191226

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200122

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200526

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20200824

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200929

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20201201

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20201210

R150 Certificate of patent or registration of utility model

Ref document number: 6810023

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250